Allergan Faces DOJ Subpoena Over Botox

Law360, New York (March 4, 2008, 12:00 AM EST) -- Deepening Allergan Inc.'s troubles over Botox, the company disclosed Monday it has been slapped with a subpoena from the U.S. Department of Justice regarding alleged promotion of off-label uses for the popular cosmetic treatment.

The company said in a statement on its Web site that the DOJ and the United States Attorney's Office for the Northern District of Georgia had asked the company to produce documents about promotional practices involving Botox for therapeutic indications.

The subpoena broadly requests documents regarding promotional, educational and other activities relating...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.